New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:37 EDTPRGOPerrigo near-term outlook has improved, says RBC Capital
RBC Capital expects Perrigo to benefit from several positive catalysts, including lower buyside expectations, tailwinds for the company's consumer health business, and increased focus on its Tysabri SPMS opportunity. The firm keeps a $160 price target and Outperform rating on the shares.
News For PRGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
10:57 EDTPRGOPerrigo completes acquisition of Omega Pharma for EUR3.8B
Subscribe for More Information
March 27, 2015
11:33 EDTPRGOPerrigo management to meet with Jefferies
Subscribe for More Information
07:45 EDTPRGOFDA to hold a public meeting
Subscribe for More Information
March 26, 2015
07:30 EDTPRGODeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 23, 2015
10:00 EDTPRGOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:25 EDTPRGOPerrigo downgraded to Sector Perform from Outperform at RBC Capital

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use